Related Experiment Video

Updated: Apr 20, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

884

Remaining challenges in childhood cancer and newer targeted therapeutics

Malcolm A Smith1, Gregory H Reaman2

  • 1Cancer Therapy Evaluation Program, National Cancer Institute, 9609 Medical Center Drive, RM 5-W414, MSC 9737, Bethesda, MD 20892, USA.

Pediatric Clinics of North America
|December 2, 2014
PubMed

Insights

Childhood cancer research is crucial as pediatric cancers differ from adult types. New drug development must consider these unique differences for effective pediatric cancer treatments.

Area of Science:

  • Pediatric Oncology
  • Cancer Biology
  • Drug Development

Background:

  • Childhood cancer remains a leading cause of death in children despite treatment advances.
  • Pediatric cancers exhibit distinct etiologies and biological characteristics compared to adult cancers.
  • Direct extrapolation of adult cancer drug efficacy and safety to children is not feasible.

Purpose of the Study:

  • To identify key factors guiding research for improved pediatric cancer treatments.
  • To address the unique challenges in developing effective therapies for childhood cancers.

Main Methods:

  • Discussion of factors influencing pediatric cancer research directions.
  • Analysis of the differences between pediatric and adult cancer biology.
  • Review of current challenges in pediatric drug development.

Main Results:

  • Pediatric cancer research requires specialized approaches distinct from adult oncology.
  • Understanding the unique biology of childhood cancers is essential for therapeutic success.
  • Several factors are critical for guiding future research in pediatric cancer treatment.

Conclusions:

  • Further research is imperative to improve outcomes for children with cancer.
  • Tailored research strategies are necessary to overcome the biological differences in pediatric malignancies.
  • Pediatric oncologists need guidance on prioritizing research avenues for novel treatment development.
Keywords:
Innovative clinical trialsPediatric cancer drug developmentPersonalized medicinePreclinical testingTargeted therapy

More Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

4.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K